Olanzapine
Product Images NDC 53002-1505

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 53002-1505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Olanzapineusp)

Chemical structure diagram of Olanzapine, showing its molecular arrangement and functional groups including a thienobenzodiazepine ring system and a methylpiperazine moiety.*

FDA Label Image

Label Image (Lbl530021505)

Label for Olanzapine 5 mg tablets by RPK Pharmaceuticals, Inc., packaged as 30 tablets. Instructions advise to take one tablet daily or as directed. The label includes refill and patient information sections, medication warnings about drowsiness and operating machinery, and space for clinic and prescriber details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.